%D9%88%D8%B1%D9%85_%D9%85%D9%8A%D9%84%D8%A7%D9%86%D9%8A%D9%86%D9%8AMelanoma%D0%9C%D1%8D%D0%BB%D1%8F%D0%BD%D0%BE%D0%BC%D0%B0%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0MelanomMelanomaMelanomMelanomaModerm%C3%A6rkekr%C3%A6ftMalignes_Melanom%DE%89%DE%AC%DE%8D%DE%A8%DE%8E%DE%B0%DE%82%DE%A6%DE%82%DE%B0%DE%93%DE%B0_%DE%89%DE%AC%DE%8D%DE%A6%DE%82%DE%AF%DE%89%DE%A7%CE%9C%CE%B5%CE%BB%CE%AC%CE%BD%CF%89%CE%BC%CE%B1MelanomaMelanomoMelanomaMelanoomMelanoma%D9%85%D9%84%D8%A7%D9%86%D9%88%D9%85%D8%A7MelanoomaM%C3%A9lanomeMeilean%C3%B3maMelanoma_maligno%D7%9E%D7%9C%D7%A0%D7%95%D7%9E%D7%94%E0%A4%AE%E0%A5%87%E0%A4%B2%E0%A5%87%E0%A4%A8%E0%A5%8B%E0%A4%AE%E0%A4%BEMelanomMelan%C3%B3ma%D5%84%D5%A5%D5%AC%D5%A1%D5%B6%D5%B8%D5%B4%D5%A1%D5%8D%D5%A5%D6%82%D5%A1%D5%B5%D5%BF%D5%B8%D6%82%D6%81MelanomaMelanoma%E6%82%AA%E6%80%A7%E9%BB%92%E8%89%B2%E8%85%AB%E1%83%9B%E1%83%94%E1%83%9A%E1%83%90%E1%83%9C%E1%83%9D%E1%83%9B%E1%83%90%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0%ED%9D%91%EC%83%89%EC%A2%85%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0Melanoma_malignumMelanomaMelanoma%E0%A4%AE%E0%A5%87%E0%A4%B2%E0%A4%BE%E0%A4%A8%E0%A5%8B%E0%A4%AE%E0%A4%BE
about
sameAs
P101
PeecoChristine KohtAnna RukkoIpilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced MelanomaProcure Tumor and Initiate Melanoma Tumor-Reactive Tumor InfiltrationDabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by SurgerySafety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting BeadsA Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell CancerCirculating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After ChemotherapyPhase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR AgonistsDenosumab + Pembrolizumab in Patients With Stage IV MelanomaCMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node DiseaseVaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV MelanomaA Study of APG-115 in Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid TumorsTest of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny DestinationsA Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in JapanCost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has SpreadEvaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic MelanomaSX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With PembrolizumabPfizer PF-06688992 in Patients With Stage III or Stage IV MelanomaThe ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) TrialTolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-oldHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerA Study of Combination With TBI-1401(HF10) and Ipilimumab in Japanese Patients With Unresectable or Metastatic MelanomaCoxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III MelanomaA Phase I/II Study of Sunitinib and DacarbazineProspective Measurement of Post-Treatment LymphedemaCompassionate Use Trial for Unresectable Melanoma With IpilimumabSorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III MelanomaInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerA Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic MelanomaSunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular MelanomaPegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by SurgeryVEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryA Study of Recombinant Vaccinia Virus to Treat Malignant MelanomaImatinib in Patients With Mucosal or Acral/Lentiginous MelanomaImatinib in Adult Patients With Metastatic Ocular MelanomaInterleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic MelanomaEducational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants
P1050
P1911
scrotum melanomaspinal cord melanomaocular melanomamalignant spindle cell melanomaepithelioid cell melanomachoroid spindle cell melanomaciliary body spindle cell melanomafamilial melanomamelanomatosisiris spindle cell melanomagallbladder melanomaskin melanomaextracutaneous melanomarecurrent cutaneous melanomauveal melanomaamelanotic melanomaAnimal-type melanomacutaneous malignant melanoma 2metastatic melanomarectal melanomaMelanoma with features of a Spitz nevusmucosal melanomaNevoid melanomasmall cell melanoma
P279
description
Krankheit
@de
Neoplàsia maligna a la pell
@ca
a bőr rosszindulatú daganata
@hu
cancer de la peau ou des muqueuses
@fr
malignant neoplasm originating from melanocytes
@en
melanositlerden kaynaklanan malign (kötü huylu) bir kanser türüdür.
@tr
melanosyyteistä eli väriaine melaniinia muodostavista soluista lähtöisin oleva syöpä
@fi
neoplasia maligna en la piel
@es
tumore maligno che origina dal ...... ta alla sintesi della melanina
@it
typ av hudcancer
@sv
name
Malign melanom
@tr
Malignes Melanom
@de
Meileanóma
@ga
Melanom
@bs
Melanom
@hr
Melanom
@lb
Melanom
@sh
Melanom
@sl
Melanom
@sr-el
Melanoma maligno
@gl
type
label
Malign melanom
@tr
Malignes Melanom
@de
Meileanóma
@ga
Melanom
@bs
Melanom
@hr
Melanom
@lb
Melanom
@sh
Melanom
@sl
Melanom
@sr-el
Melanoma maligno
@gl
altLabel
Føflekkreft
@nb
MELANOMA, MALIGNANT
@en
Maligne melanoom
@nl
Maligni melanom
@bs
Maligni melanom
@hr
Malingt Melanom
@sv
Melanom
@de
Melanom
@nb
Melanom
@sv
Melanoma malignus
@la
prefLabel
Malign melanom
@tr
Malignes Melanom
@de
Meileanóma
@ga
Melanom
@bs
Melanom
@hr
Melanom
@lb
Melanom
@sh
Melanom
@sl
Melanom
@sr-el
Melanoma maligno
@gl